Objective

• Set the scene: health environment, health policies, market access regulations across a broad range of countries. Country-specific policies are presented by Public Agency Representatives.
• Impact of COVID-19 pandemic on pharmaceutical industry business model and focus on market access (NEW)

Activities

• Introduction to market access definition, concept, and principles
  • National stakeholders
  • Regional stakeholders
  • Local stakeholders
  • Why has market access emerged? Decision-making chain
  • Market access strategies
    • Adapting the strategy for each market access stakeholder
• Market access policies in Europe
• Market access policies outside Europe (USA, Canada, Australia, Japan and China)
• Market access perspectives and drug development
• Key activities, outputs and benefits from Phase I to LCM: what should you do and when should you do it?
• Impact of COVID-19 pandemic on pharmaceutical industry business model and focus on market access (NEW)

Workshop & Case study